Literature DB >> 3279678

Amelioration of normothermic canine liver ischemia with prostacyclin.

S Todo1, H Yokoi, L Podesta, P ChapChap, C Pan, K Okuda, Y Kamiyama, J Demetris, L Makowka, S Iwatsuki.   

Abstract

A model of hepatic ischemia was developed in dogs using a pump-driven splanchnic-to-jugular vein bypass during crossclamping of the portal triad. An LD50 was established with three hours of ischemia. PGI2 given for one hour before the ischemic insult ameliorated the ischemic injury and increased survival.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3279678      PMCID： PMC2962588     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


  9 in total

1.  Some effects of interrupting hepatic blood flow.

Authors:  T DRAPANAS; D R BECKER; G S ALFANO; W H POTTER; J D STEWART
Journal:  Ann Surg       Date:  1955-11       Impact factor: 12.969

2.  The effect of hepatic ischaemia on liver function and the restoration of liver mass after 70 per cent partial hepatectomy in the dog.

Authors:  M A O'Keane; C M Furnival; M A O'keane; L H Blumgart
Journal:  Br J Surg       Date:  1975-06       Impact factor: 6.939

3.  Predictive value of liver biochemistry in acute hepatic ischemia.

Authors:  E F Farkouh; A M Daniel; J G Beaudoin; L D MacLean
Journal:  Surg Gynecol Obstet       Date:  1971-05

4.  Role of prostaglandins (PGI2) in improving the survival of ischemically damaged liver allografts.

Authors:  L H Toledo-Pereyra
Journal:  Trans Am Soc Artif Intern Organs       Date:  1984

5.  Tolerance of the liver to ischemia in the pig.

Authors:  K A Harris; A C Wallace; W J Wall
Journal:  J Surg Res       Date:  1982-12       Impact factor: 2.192

6.  Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin.

Authors:  M Monden; J G Fortner
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

7.  Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion.

Authors:  E Delva; J P Barberousse; B Nordlinger; J M Ollivier; B Vacher; C Guilmet; C Huguet
Journal:  Surgery       Date:  1984-03       Impact factor: 3.982

8.  An experimental study of survival after two hours of normothermic hepatic ischemia.

Authors:  B Nordlinger; D Douvin; L Javaudin; P Bloch; A Aranda; M Boschat; C Huguet
Journal:  Surg Gynecol Obstet       Date:  1980-06

9.  Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury.

Authors:  O Sikujara; M Monden; K Toyoshima; J Okamura; G Kosaki
Journal:  Transplantation       Date:  1983-09       Impact factor: 4.939
  9 in total
  4 in total

Review 1.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

2.  Efficacy of prostaglandin I2 analog on liver grafts subjected to 30 minutes of warm ischemia.

Authors:  A Kishida; Y Kurumi; M Kodama
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Comparison of various lazaroid compounds for protection against ischemic liver injury.

Authors:  N Ishizaki; Y Zhu; S Zhang; A Nemoto; Y Kobayashi; V M Subbotin; R G Lee; T E Starzl; S Todo
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

4.  Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.

Authors:  E Totsuka; S Todo; Y Zhu; N Ishizaki; Y Kawashima; M B Jin; A Urakami; T Shimamura; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-09       Impact factor: 6.113
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.